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Synthetic cannabinoids represent an in-
creasingly popular trend, and acute intoxi-
cation is widely seen in emergency rooms 
and intensive care units (ICU), as they are 
inexpensive and easily accessible. Cannab-
inoids mediate their effects through bind-
ing specific receptors which are members 
of the G protein coupled receptor super-
family. Cannabinoid-2 receptors are pri-
marily found in the immune system and 
mediate immunosuppression by inducing 
apoptosis, inhibition of proliferation and 
suppression of cytokine and chemokine 
production. Many studies have discussed 
the effects of cannabinoids on the hema-
tological and immune systems but con-
troversial results have been reported. The 
aim of this study was to identify laboratory 
findings of acute synthetic cannabinoid in-
toxication. Forty-two patients, admitted to 
the ‘Anesthesia intensive care unit’ between 
2014 and 2015 with synthetic cannabinoid 
intoxication, were studied retrospectively 
to assess the relationship between synthet-
ic cannabinoid intoxication and complete 
blood count (white blood cells (WBC), 
neutrophils, lymphocytes, monocytes, 
eosinophils, basophils) and neutrophil to 
lymphocyte ratio. WBC neutrophil count 
decreased at ICU discharge when com-
pared to ICU admission (p<0.001). The ra-
tio of neutrophils to lymphocytes was also 
lower at ICU discharge when compared to 
ICU admission (p<0.05).
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INTRODUCTION
Synthetic cannabinoids represent an in-
creasingly popular trend, and acute intoxi-
cation is widely seen in emergency rooms 
(ER) and intensive care units (ICU), as 
they are inexpensive and easily accessible. 
Use of synthetic cannabinoids has psychi-
atric, medical, and social consequences. 
They are found in powder form or loose 
leaf form. Powder form may be dissolved 
and sprayed onto a dried herbal substrate 
and packed, or purchased as a pre-rolled 
product. Various flavors may be added and 
they may contain different synthetic can-
nabinoids as well as preservatives, addi-
tives, amides, esters and benzodiazepines. 
These products are sold on the streets and 
they are typically smoked in cigarette pa-
pers or cannabis pipes. (1) Some of these 
products are marketed under different 
names and forms from head shops (a head 
shop is a retail outlet specializing in equip-
ment used for consumption of cannabis 
and tobacco and items related to cannabis 
culture and related countercultures; prod-
ucts may include magazines (e.g., about 
cannabis culture, cannabis cultivation, 
tattooing and music) and gas stations). 
Ingredients change over time to avoid leg-
islation. When a compound is banned, it 
is replaced by a pharmacologically similar 
compound to avoid regulations. (2) Thus, 
it can cause different clinical findings, de-
pending on the ingredients.
Phytocannabinoids, or plant-derived can-
nabinoids, include delta-9-tetrahydrocan-
nabinol (THC), the primary psychoactive 
component of cannabis. Cannabinoids 
mediate their effects through binding spe-
cific receptors which are members of the G 
protein coupled receptor superfamily. To 
date, two cannabinoid receptors have been 
identified: Cannabinoid-1 receptors (CB1) 
and Cannabinoid-2 receptors (CB2). CB1 
are expressed primarily in the central nerv-
ous system (CNS) and are responsible for 
the psychoactive effects of cannabinoids 
by modulating neurotransmitter release. 
In contrast, CB2 are localized primar-
ily in immune cells such as lymphocytes, 
macrophages and neutrophils and are re-
sponsible for immunomodulatory effects 
of cannabinoids. (1,3,4) While THC is a 
low-efficacy partial agonist of cannabinoid 
receptors, the synthetic cannabinoids are 
high-potency full agonists for CB1 recep-
tors. (5)
Most synthetic cannabinoids are not cur-
rently found using routine toxicology 
screening as they contain synthetic can-
nabinoids from different chemical classes. 
Some synthetic cannabinoids can be meas-
ured in the serum using chromatographic 
methods with mass spectrometry but these 
tests cannot be performed in many hos-
pitals and they are time consuming and 
expensive. (1,6) Single use of THC can be 
detected up to 3 days while daily use can be 
detected up to 10 days. (6)
While many of the acute effects are simi-
lar to the effects of cannabis, these effects 
may differ clinically in terms of intensity 
and it is unclear whether they are related 
to the differences between synthetic can-
nabinoids and THC or to the noncan-
nabinoid components. (1) These effects in-
clude mood disorders (euphoria, negative 
mood), anxiety, psychosis, cognitive and 
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neurological function disorders (dizziness, 
seizures, tremor, ataxia). Cardiovascular 
effects include tachycardia, bradycardia, 
ECG changes, and arrhythmias. Synthetic 
cannabinoids also induce dry mouth, 
reddened conjunctiva, pupillary changes 
including miosis and mydriasis, blurry 
vision and light sensitivity. In addition 
to psychiatric and physical symptoms, a 
number of acute changes in laboratory pa-
rameters have been reported in individu-
als who have intoxication. Hyperglycemia, 
hypokalemia, elevated creatinine, acidosis, 
elevated phosphokinase and elevated white 
blood cell count are reported. (1,7)
Many recent studies have indicated that 
the neutrophil to lymphocyte ratio (NLR) 
is a significant inflammatory marker in di-
agnosis of various diseases such as pulmo-
nary thromboembolism, (8) malignancy, 
(9) cardiovascular (10) and inflammatory 
diseases. (11) It is also an inexpensive in-
flammatory marker that provides quick 
results. In this study we aimed to identify 
laboratory findings of acute synthetic can-
nabinoid intoxication and to assess the re-
lationship between synthetic cannabinoid 
intoxication and NLR.
MATERIAL AND METHODS
A total of 56 patients admitted to the ICU 
between 2014 and 2015 with synthetic 
cannabinoid intoxication were studied 
retrospectively after approval by the local 
ethics committee. Synthetic cannabinoid 
intoxication information was obtained by 
witnesses or evidence such as loose leaf 
forms or rolled cigarettes found with the 
patient. All patients included in the study 
had used synthetic cannabinoids with in-
halation and smoking, no ingestion case 
was reported. Forty-two patients, with lab-
oratory results from admission to ER and 
discharge from ICU, were included in our 
study, whereas patients with missing data 
and with concomitant alcohol use (with 
blood ethanol levels more than 50 mg/
dL) were excluded. Laboratory results of 
complete blood count (WBC, neutrophils, 
lymphocytes, monocytes, eosinophils, and 
basophils) duration of ICU stay, age, and 
intubation data were recorded. Neutrophil 
Lymphocyte Ratio was calculated both on 
admission and discharge. Leukocytosis 
was defined as a WBC >10.5×103cells/µL 
and leukopenia was defined as WBC count 
< 4.0×103 cells/µL. Received data was 
analyzed with SPSS 15.0. Continuous vari-
ables were represented as mean ± SD. Ap-
propriateness of the variables to a normal 
distribution was analyzed with Kolmog-
orov-Smirnov test. Data were compared 
with paired T Test. A p< 0.05 was deemed 
statistically significant.
RESULTS
A total of 42 patients were included in the 
study. All patients were male and aged be-
tween 21-28 (22 ± 1.6) (mean±SD) years 
of age. Mean ICU duration was 1.66 ± 0.4 
days. All patients had neurocognitive dis-
orders, 4 patients (9.5%) had respiratory 
disorders that needed intubation and me-
chanical ventilation. Laboratory tests at 
both admission and discharge were com-
pared statistically. 24 patients (57%) had 
leukocytosis and none of them had leuko-
penia on ER admission, and only 7 (16%) 
patients had leukocytosis on discharge. 
WBC and neutrophil count decreased at 
ICU discharge when compared to ICU 
admission (p<0.001) (table 1). NLR was 
found to be 5.5 ± 4.7 on admission and 2.7 
± 2.2 on ICU discharge (table 1). The NLR 
was also decreased on ICU discharge when 
compared to ICU admission (p<0.05) (ta-
ble 1).
Table 1. Comparison of data between intensive care unit (ICU) admission and discharge.
ICU admission ICU discharge p
WBC 11.7 ± 4.0 8.7 ± 2.7 <0.001
Neutrophil 8.7 ± 4.0 5.5 ± 2.8 <0.001
Lymphocyte 2.11 ± 1.01 2.35 ± 0.57 0.161
Monocyte 0.71 ± 0.40 0.65 ± 0.26 0.305
Eosinophil 0.11 ± 0.11 0.15 ± 0.11 0.110
Basophil 0.04 ± 0.03 0.03 ± 0.04 0.782
Platelet 229.7 ± 73.5 215.7 ± 53.3 0.94
NLR 5.5 ± 4.7 2.7 ± 2.2 0.01
NLR, Neutrophil to lymphocyte ratio; WBC, White blood cells.
DISCUSSION
Cannabinoids are a group of compounds 
that mediate their effects through cannabi-
noid receptors CB1 and CB2, which are G 
protein coupled receptors found on im-
mune system cells. While CB1 is expressed 
in the CNS and plays a role in modulating 
GABA and glutamate neurotransmission, 
CB2 is primarily found in the immune 
system and mediates immunosuppres-
sion by inducing apoptosis, inhibition of 
proliferation and suppression of cytokine 
and chemokine production. (12-14) THC 
is the major active ingredient in marijuana 
which is a low efficiency partial agonist 
of cannabinoid receptors. Synthetic can-
nabinoids are high efficiency full agonists 
of CB thus consequences of synthetic can-
nabinoid use differs from marijuana-like 
effects. Also some synthetic cannabinoids 
have long half-lives as a result of active me-
tabolites. (1,14)
The neutrophil to lymphocyte ratio has 
been widely used in identifying the degree 
of inflammation, as white blood cell count 
and its subtypes play an important role in 
inflammatory processes. NLR is claimed 
to be more useful as it is a combination 
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of two independent inflammatory mark-
ers. (15,16) However, no studies have been 
found regarding NLR in acute synthetic 
cannabinoid intoxication.
Many studies have discussed the effects of 
cannabinoids on the hematological and 
immune system but controversial results 
have been reported. Oseni at al. studied the 
effects of marijuana smoking on some he-
matological parameters, including WBC, 
hemoglobin, platelets and NLR, and found 
no significant difference with non-smokers 
in contrast to our study. (16) However they 
included smokers that used marijuana for 
at least two years which differs from our 
study population, as inexperienced smok-
ers had symptoms of dizziness, tachycar-
dia, tremor and disorientation while expe-
rienced users did not.
Altınısık et al. reported a series of synthetic 
cannabinoid intoxication cases, followed 
up in ICU, with leukocytosis in 33%, and 
leukopenia in 8% of cases. (7) However 
they mainly focused on clinical presenta-
tion of intoxication. In our study 24 pa-
tients (57%) had leukocytosis and none 
of them had leukopenia on ER admission, 
and only 7 (16%) patients had leukocytosis 
on discharge.
Mukhtar et al. reported a decrease in total 
WBC count and neutrophil count in rats 
treated with intramuscular cannabinoid 
extract administration compared to the 
control group. Another animal study by 
Obembe et al. reported a decrease in to-
tal WBC in groups fed different doses of 
cannabis sativa solution. Authors attrib-
uted the results to bone narrow supression 
which disturbs maturation of monocytes, 
as the design of these studies aimed at ef-
fects of chronic use. (17,18)
Limitations of our study include the rela-
tively small sample size and our retrospec-
tive study design. Also we could not deter-
mine or obtain any information about the 
type of synthetic cannabinoid used, which 
may have affected our results. We also did 
not know if the patient was a chronic user 
of synthetic cannabinoids, other drugs or 
cannabis, which may have affected our re-
sults. As we focused on acute intoxication 
of synthetic cannabinoids, we compared 
WBC and NLR of patients admitted to 
ICU with an altered level of consciousness, 
with their control blood samples taken at 
discharge. Our study would be more valu-
able if we had obtained follow up results 
over a larger time interval.
CONCLUSIONS
Neutrophil count and neutrophil to lym-
phocyte ratio were decreased in discharge 
blood samples indicating hematological 
characteristics of synthetic cannabinoid 
intoxication. Cannabinoids have a po-
tential use as anti-inflammatory agents 
against inflammatory and autoimmune 
diseases as well as for, treating sepsis. How-
ever synthetic cannabinoids differ from 
cannabinoids with their high potency and 
full agonist properties and therefore fur-
ther studies should be performed on this 
subject.
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